Free Trial

Summit Financial LLC Has $225,000 Stock Holdings in Xylem Inc. $XYL

Xylem logo with Business Services background

Key Points

  • Summit Financial LLC reduced its stake in Xylem Inc. by 67.6%, now holding 1,887 shares worth $225,000 as of the latest quarter.
  • Several hedge funds, including Vanguard Group and Price T Rowe Associates, have increased their holdings in Xylem, indicating strong institutional interest with 87.96% of the stock owned by institutional investors.
  • Xylem reported earnings of $1.26 per share, surpassing analyst expectations, with quarterly revenue rising to $2.30 billion, reflecting a 6.1% year-over-year growth.
  • Looking to export and analyze Xylem data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Summit Financial LLC cut its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 67.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,887 shares of the industrial products company's stock after selling 3,933 shares during the quarter. Summit Financial LLC's holdings in Xylem were worth $225,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in XYL. Price T Rowe Associates Inc. MD lifted its position in Xylem by 689.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company's stock worth $443,074,000 after buying an additional 3,239,203 shares in the last quarter. Northern Trust Corp raised its holdings in shares of Xylem by 42.0% in the 4th quarter. Northern Trust Corp now owns 3,268,433 shares of the industrial products company's stock valued at $379,204,000 after purchasing an additional 966,399 shares during the period. Nuveen LLC bought a new stake in shares of Xylem in the 1st quarter valued at about $99,726,000. OVERSEA CHINESE BANKING Corp Ltd raised its holdings in shares of Xylem by 390.5% in the 1st quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 1,021,337 shares of the industrial products company's stock valued at $122,009,000 after purchasing an additional 813,100 shares during the period. Finally, Vaughan Nelson Investment Management L.P. bought a new stake in shares of Xylem in the 1st quarter valued at about $89,828,000. 87.96% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

XYL has been the topic of a number of research analyst reports. JPMorgan Chase & Co. initiated coverage on shares of Xylem in a report on Friday, May 30th. They issued an "overweight" rating and a $148.00 target price on the stock. Royal Bank Of Canada upped their target price on shares of Xylem from $143.00 to $147.00 and gave the company an "outperform" rating in a report on Wednesday, April 30th. Cowen reaffirmed a "hold" rating on shares of Xylem in a report on Tuesday. Stifel Nicolaus upped their target price on shares of Xylem from $162.00 to $175.00 and gave the company a "buy" rating in a report on Friday, August 1st. Finally, Citigroup reaffirmed a "buy" rating and issued a $152.00 target price (up from $137.00) on shares of Xylem in a report on Monday, July 14th. Six analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. Based on data from MarketBeat, Xylem presently has a consensus rating of "Moderate Buy" and an average target price of $152.29.

Get Our Latest Report on XYL

Xylem Stock Performance

Shares of NYSE:XYL traded down $0.63 on Thursday, reaching $143.99. 961,010 shares of the company's stock were exchanged, compared to its average volume of 1,237,550. The company has a fifty day moving average of $135.71 and a 200-day moving average of $126.80. Xylem Inc. has a twelve month low of $100.47 and a twelve month high of $145.33. The company has a market capitalization of $35.05 billion, a price-to-earnings ratio of 37.40, a PEG ratio of 2.50 and a beta of 1.11. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17.

Xylem (NYSE:XYL - Get Free Report) last announced its earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The firm had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. During the same quarter in the prior year, the business posted $1.09 EPS. The business's revenue was up 6.1% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, research analysts predict that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Thursday, August 28th. Xylem's dividend payout ratio is presently 41.56%.

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Articles

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines